一个wide variety of process steps are required for the filling of vaccines – from washing and sterilizing the vials to filling and closing. All system components are tested and accepted as part of the CSPE approach at Optima in Schwaebisch Hall.
Optima
Catalent recently announced that it has signed an agreement with a major global pharmaceutical company to accelerate availability of manufacturing capacity and prepare for large-scale commercial manufacturing of a lead vaccine candidate for COVID-19 at Catalent’s facility in Bloomington, Indiana. Scale-up in production will include the use of an Optima high-speed vial filling line.
